Side effects may increase when combining both medications, including gastrointestinal issues and elevated heart rate or blood pressure
GLP-1 medications increase sensitivity to sweet tastes, making heavily flavored or artificially sweetened products difficult to tolerate
Diseases such as diabetes, autoimmune disorders, or poor circulation can delay healing or increase the risk of infection or other complications
Biological effects of GIP The Gastric Inhibitory Polypeptide (GIP), isolated for the first time from porcine small intestine in 1971 [27], was named as GIP on the basis of its ability to inhibit gastric hydrochloric acid secretion [28]
donors experiencing active gastrointestinal symptoms should postpone donation until symptoms resolve
Contact a lawyer who has extensive experience in handling cases involving Ozempic or other semaglutide drugs, particularly those linked to serious side effects such as blindness/vision loss, stomach paralysis, and intestinal blockages